Journey Medical Corporation
DERM
$5.33
$0.020.38%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.45% | 102.15% | 89.17% | 87.00% | 69.68% |
| Total Depreciation and Amortization | -21.45% | -25.04% | -18.50% | -11.68% | 17.49% |
| Total Amortization of Deferred Charges | -41.89% | -43.47% | 507.58% | 465.08% | -81.23% |
| Total Other Non-Cash Items | -38.34% | -51.43% | 29.91% | 19.31% | -52.40% |
| Change in Net Operating Assets | -201.58% | -196.28% | -143.91% | -126.75% | 217.86% |
| Cash from Operations | -255.50% | 1.69% | 107.66% | 138.72% | 238.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | 100.00% | 75.00% | 76.42% |
| Cash from Investing | 100.00% | 100.00% | 100.00% | 75.00% | 76.42% |
| Total Debt Issued | -39.55% | -47.37% | -60.53% | 73.65% | 23.30% |
| Total Debt Repaid | 98.21% | 75.26% | 26.12% | -565.41% | -460.00% |
| Issuance of Common Stock | 26,456.00% | 18,370.59% | 4,302.82% | 3,150.00% | -99.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | 84.44% | 95.74% |
| Cash from Financing | 210.92% | 284.93% | -162.60% | -129.19% | -148.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.44% | 132.76% | 86.59% | 73.28% | -176.82% |
